PGxDB: an interactive web-platform for pharmacogenomics research
2025

PGxDB: A Web Platform for Pharmacogenomics Research

publication Evidence: high

Author Information

Author(s): Duong Nguyen Trinh Trung, Tanoli Ziaurrehman, Hassan Saad, Özcan Umut Onur, Caroli Jimmy, Kooistra Albert J, Gloriam David E, Hauser Alexander S

Primary Institution: University of Copenhagen

Hypothesis

How can an interactive web-based platform improve access to pharmacogenomics data?

Conclusion

PGxDB provides a comprehensive and user-friendly platform for analyzing genetic data related to drug responses, facilitating personalized medicine.

Supporting Evidence

  • Pharmacogenomics can reduce adverse drug reactions, which are a leading cause of hospitalizations.
  • PGxDB integrates data from multiple sources to provide a comprehensive analysis platform.
  • The platform supports clinical decision-making and drug discovery.

Takeaway

PGxDB is like a big online toolbox that helps doctors and scientists understand how our genes affect how we respond to medicines, making treatments safer and more effective.

Methodology

The platform integrates diverse data types, including drug profiles, genetic data, and adverse reactions, allowing users to explore relationships between drugs and genetic profiles.

Limitations

The platform may have inconsistencies in ID mappings and coverage of adverse drug reactions.

Digital Object Identifier (DOI)

10.1093/nar/gkae1127

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication